This is a copy of the September 2nd edition of our weekly Newsletter, which we have been publishing since October, 2015. Friends, We were always expecting a fast and...
CV Sciences, Inc. provides corporate update to shareholders LAS VEGAS, Aug. 30, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) would like...
This is a copy of the August 19th edition of our weekly Newsletter, which we have been publishing since October, 2015. Friends, What a fantastic event in Toronto this...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$2.5 million per quarter. This...
Exclusive Interview with CEO and CFO of CV Sciences Joe Dowling CV Sciences, a consumer products and pharmaceutical cannabis company, reported $12.3 million in sales for the second quarter...
This is a copy of the August 5th edition of our weekly Newsletter, which we have been publishing since October, 2015. Friends, Cross-industry and cross-border investments have been on...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$2.5 million per quarter....
Cannabis stocks, as measured by the Global Cannabis Stock Index, fell again in July, declining 10.0% to 90.12 after posting a new 2018 low: The index, which had 53 qualifying members that...
CV Sciences, Inc. Reports Second Quarter 2018 Financial Results Growth and Profitability Driven by Key Financial Performance Metrics, including Record GAAP Net Income of $3.2 Million Management to Host...
This is a copy of the July 29th edition of our weekly Newsletter, which we have been publishing since October, 2015. Just four weeks ago, we reflected on the...
CV Sciences, Inc. Pre-Announces Record Second Quarter 2018 Sales Company Expects to Report Sales of $12.3 Million, up 203% from the same quarter in 2017 Will Host Earnings Call...
CV Sciences, Inc. Files Application for Up-Listing to the NASDAQ Capital Market LAS VEGAS, July 23, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of...
Cannabis stocks, as measured by the Global Cannabis Stock Index, fell again in June, declining 4.5% to 100.12, after going into the final week of the month with a small gain: The...
CV Sciences, Inc. Settles SEC Matter The Company Names New Chief Executive Officer, President and Board Member LAS VEGAS, June 01, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI)...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5 million per quarter...
CV Sciences, Inc. Reports First Quarter 2018 Financial Results – Record Quarter on All Key Financial Performance Metrics Including 114% Increase in Sales Year-Over-Year and Double Digit Sequential Sales...
Last week, GW Pharma (NASDAQ: GWPH) scored a milestone victory, as the thirteen-member panel at the Peripheral and Central Nervous System Drugs Advisory Committee, which met on April 19th to consider...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5 million per quarter...
CV Sciences, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results – Record Year on All Key Financial Performance Metrics – Management to Host Webcast on March 29,...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5m per quarter. This...
CV Sciences, Inc. Reports Third Quarter 2017 Financial Results – Record Quarter for all Financial Performance Metrics – Management to Host Webcast on November 8, 2017 to Discuss Q3...
In contrast to a period when promotion and fluff have grabbed the attention of novice stock investors interested in the legal cannabis theme since early 2013, we are now seeing companies...
After the close on Friday, the SEC announced that it has filed suit against Michael Mona, Jr., CEO of CV Sciences (OTC: CVSI) and the company, which was formerly...
As the U.S. cannabis industry has evolved over the past few years, so has the market for publicly-traded cannabis stocks. In 2014, very few publicly-traded companies were reporting substantial...
Hemp Business Journal (HBJ), the definitive source for market sizes and high-level analysis of business trends in the hemp industry, followed up its initial market research piece, The State of...
